[Methyl-ter-butyl ether (MTBE) therapy of cholesterol biliary calculosis. First long-term controls (up to 22 months)].
The results and clinical and instrumental examinations of 12 patients at least 6 months after MTBE treatment for cholesterine biliary calculosis are presented. No recurrence of stones or alterations to the biliary ways or duodenal mucosa attributable to MTBE were encountered.
Divisione di Medicina Interna, Ospedale Gradenigo, Torino.
S
S
Gabasio
L
L
Bonardi
G
G
Colombo
E
E
Juliani
A
A
Leone
G
G
Gandini
D000328:Adult; D000368:Aged; D001649:Bile Duct Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy; D002769:Cholelithiasis / Q000032:analysis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D002784:Cholesterol / Q000032:analysis; D004987:Ethers / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008738:Methyl Ethers; D008875:Middle Aged; D011859:Radiography
D004987:Ethers; D008738:Methyl Ethers; C043243:methyl tert-butyl ether; D002784:Cholesterol
Trattamento con metil-ter-butil etere (MTBE) della calcolosi biliare colesterinica. Primi controlli a distanza (fino a 22 mesi).